- UroToday Home
- Urologic Oncology
The Latest Research on CRPC with Bone Metastases
Recent Abstracts
-
Neuronal calcitonin gene-related peptide promotes prostate tumor growth in the bone microenvironment.CRPC w/ bone metastasesOctober 22, 2020
-
FOXA2 promotes prostate cancer growth in the bone.CRPC w/ bone metastasesOctober 14, 2020
-
A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer.CRPC w/ bone metastasesOctober 12, 2020
-
Radiotherapy Practice for Treatment of Bone Metastasis in Ethiopia.CRPC w/ bone metastasesOctober 8, 2020
-
Bone pain palliation outcomes and possibility of Radium-223 re-treatment in mCRPC.CRPC w/ bone metastasesOctober 7, 2020
-
The botanical component p-hydroxycinnamic acid suppresses the growth and bone metastatic activity of human prostate cancer PC-3 cells in vitro.CRPC w/ bone metastasesOctober 2, 2020
-
Differential expression of NKX 3.1 and HOXB 13 in bone metastases originating from prostatic carcinoma among the Egyptian males.CRPC w/ bone metastasesSeptember 30, 2020
-
Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT.CRPC w/ bone metastasesSeptember 28, 2020
-
Dynamic changes of bone metastasis predict bone-predominant status to benefit from radium-223 dichloride for patients with castration-resistant prostate cancer.CRPC w/ bone metastasesSeptember 25, 2020
-
The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer.CRPC w/ bone metastasesSeptember 24, 2020
Beyond the Abstracts
-
Bone Targeted Therapy and Skeletal Related Events in the Era of Enzalutamide and Abiraterone Acetate for Castration Resistant Prostate Cancer with Bone Metastases - Beyond the AbstractCRPC w/ bone metastasesOctober 27, 2020
-
Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT: Beyond the AbstractCRPC w/ bone metastasesApril 7, 2017
-
Prostate Cancer Cure is Possible: Beyond the AbstractCRPC w/ bone metastasesJanuary 5, 2017
-
The use of radium 223 dichloride in a multidisciplinary approach for treating metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Elisa BorsòCRPC w/ bone metastasesFebruary 11, 2015